什么是权益披露？On December 9, it was reported that, according to documents disclosed by the Hong Kong Stock Exchange on December 9, CITIC Securities Company Limited increased its shareholding on December 4 at an average price of HK$20.8751 per share.$SINOPHARM (01099.HK)$1.61 million shares of common stock were valued at approximately HK$33.6089 million. After the increase, the latest number of shares held by CITIC Securities Company Limited is 95.3028 million shares, with the good stock ratio rising from 6.98% to 7.10%.
Additional information: The equity is held by citic sec asset management company on behalf of all the asset management plans it manages, disclosing the shares of sinopharm holdings limited - H share equity.
What is equity disclosure?
According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the company's shares) must disclose their shareholding in the listed company. Directors and senior executives of the listed company must disclose their shareholding and equity certificate rights in the listed company and any related companies.
Why is equity disclosure important?
Equity disclosure enables investors to identify (1) individuals who control or have the ability to control the shareholding of the listed company and (2) individuals who may benefit from transactions involving entities related to the listed company.
